Maximizing the extent of tumor resection during transsphenoidal surgery for pituitary macroadenomas: can endoscopy replace intraoperative magnetic resonance imaging?
Authors:
- 1 April 2010
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 112 (4) , 736-743
Abstract
Object: Endoscopic approaches to pituitary tumors have become an effective alternative to traditional microscopic transsphenoidal approaches. Despite a proven potential to decrease unexpected residual tumor, intraoperative MR (iMR) imaging is infrequently used even in the few operating environments in which such technology is available. Its use is prohibitive because of its cost, increased complexity, and longer operative times. The authors assessed the potential of intrasellar endoscopy to replace the need for iMR imaging without sacrificing the maximum extent of resection. Methods: In this retrospective study, 27 consecutive patients underwent fully endoscopic resection of pituitary macroadenomas. Intrasellar endoscopy was used to determine the presence of residual tumor within the sella turcica and tumor cavity. Intraoperative MR imaging was used to identify rates of unexpected residual tumor and the need for further tumor resection. Results: Intraoperative estimates of the extent of tumor resection were correct in 23 patients (85%). Of 4 patients with unacceptable tumor residuals, 3 underwent further tumor resection. After iMR imaging, the rate of successful completion of the planned extent of resection increased to 26 patients (96%). Rates of both endocrinopathy reversal and postoperative complications were consistent with previously published results for microscopic and endoscopic resection techniques. Conclusions: The findings in this study provided quantitative evidence that intrasellar endoscopy has significant promise for maximizing the extent of tumor resection and is a useful adjunct to surgical approaches to pituitary tumors, particularly when iMR imaging is unavailable. A larger prospective study on the extent of resection following endoscopic transsphenoidal surgery would strengthen these findings.Keywords
This publication has 44 references indexed in Scilit:
- Surgical treatment for severe visual compromised patients after pituitary apoplexyJournal of Neuro-Oncology, 2006
- Determinants of neurosurgical outcome in pituitary tumorsJournal of Endocrinological Investigation, 2005
- Surgical management of adrenocorticotropic hormone—secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndromeJournal of Neurosurgery, 2005
- Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression testJournal of Neurosurgery, 2003
- Endoscopic Endonasal Transsphenoidal Approach: Outcome Analysis of 100 Consecutive Proceduresmin - Minimally Invasive Neurosurgery, 2002
- Endoscopic Transsphenoidal Approach: Adaptability of the Procedure to Different Sellar LesionsNeurosurgery, 2002
- Intraoperative Magnetic Resonance Imaging to Determine the Extent of Resection of Pituitary Macroadenomas during Transsphenoidal MicrosurgeryNeurosurgery, 2001
- Endoscopic Endonasal Transsphenoidal Surgery in Recurrent and Residual Pituitary Adenomas: Technical Note1min - Minimally Invasive Neurosurgery, 2000
- Endoscopic Endonasal Transsphenoidal Approach: An Additional Reason in Support of Surgery in the Management of Pituitary LesionsJournal of Neurological Surgery Part B: Skull Base, 1999
- Transsphenoidal Microsurgery for Growth Hormone-Secreting Pituitary Adenomas: Initial Outcome and Long-Term ResultsThe Journal of Clinical Endocrinology & Metabolism, 1998